UPMC PASSAVANT
The Sunshine Act requires manufacturers to report payments to teaching hospitals as institutions, separately from payments to individual physicians. These figures are money reported to the hospital itself — most of it research funding and grants, not compensation to any named doctor.
- Total reported
- $595K
- Transactions
- 95
- Companies
- 24
- Average per transaction
- $6,263
Who reported the payments
| Takeda Pharmaceuticals U.S.A., Inc. | $403,211 |
| Angiodynamics, Inc. | $67,022 |
| Olympus America Inc. | $23,775 |
| Smith+Nephew | $21,750 |
| Convatec Inc. | $13,500 |
| Molnlycke Health Care US, LLC | $9,000 |
| AbbVie | $8,500 |
| Organogenesis Inc. | $7,500 |
| Paratek Pharmaceuticals, Inc. | $7,000 |
| Baxter Healthcare | $6,000 |
| GSK | $5,608 |
| Medline Industries LP | $5,000 |
| KCI USA, Inc. | $3,899 |
| Integra Lifesciences Corporation | $2,500 |
| Zimmer Biomet | $2,495 |
| Edwards Lifesciences | $2,410 |
| Stryker | $1,592 |
| KARL Storz Endoscopy-america | $1,410 |
| Pinnacle Biologics, Inc | $1,100 |
| Coloplast | $500 |
| Hollister Incorporated | $500 |
| Linvatec Corporation | $297 |
| Abbott | $250 |
| CSL Behring | $140 |